About Technology Issues FAQ

Links

Clinical experience with the combined use of recombinant interleukin-2 (IL2) and interferon alfa-2a (IFNα) in metastatic melanoma

Clinical experience with the combined use of recombinant interleukin-2 (IL2) and interferon alfa-2a (IFNα) in metastatic melanoma — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.